UniProt ID | ABCF3_HUMAN | |
---|---|---|
UniProt AC | Q9NUQ8 | |
Protein Name | ATP-binding cassette sub-family F member 3 | |
Gene Name | ABCF3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 709 | |
Subcellular Localization | ||
Protein Description | Displays an antiviral effect against flaviviruses such as west Nile virus (WNV) in the presence of OAS1B.. | |
Protein Sequence | MATCAEILRSEFPEIDGQVFDYVTGVLHSGSADFESVDDLVEAVGELLQEVSGDSKDDAGIRAVCQRMYNTLRLAEPQSQGNSQVLLDAPIQLSKITENYDCGTKLPGLLKREQSSTVNAKKLEKAEARLKAKQEKRSEKDTLKTSNPLVLEEASASQAGSRKESRLESSGKNKSYDVRIENFDVSFGDRVLLAGADVNLAWGRRYGLVGRNGLGKTTLLKMLATRSLRVPAHISLLHVEQEVAGDDTPALQSVLESDSVREDLLRRERELTAQIAAGRAEGSEAAELAEIYAKLEEIEADKAPARASVILAGLGFTPKMQQQPTREFSGGWRMRLALARALFARPDLLLLDEPTNMLDVRAILWLENYLQTWPSTILVVSHDRNFLNAIATDIIHLHSQRLDGYRGDFETFIKSKQERLLNQQREYEAQQQYRQHIQVFIDRFRYNANRASQVQSKLKMLEKLPELKPVDKESEVVMKFPDGFEKFSPPILQLDEVDFYYDPKHVIFSRLSVSADLESRICVVGENGAGKSTMLKLLLGDLAPVRGIRHAHRNLKIGYFSQHHVEQLDLNVSAVELLARKFPGRPEEEYRHQLGRYGISGELAMRPLASLSGGQKSRVAFAQMTMPCPNFYILDEPTNHLDMETIEALGRALNNFRGGVILVSHDERFIRLVCRELWVCEGGGVTRVEGGFDQYRALLQEQFRREGFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATCAEILR ------CCCHHHHHH | 16.04 | 22223895 | |
3 | Phosphorylation | -----MATCAEILRS -----CCCHHHHHHH | 15.79 | 20860994 | |
79 | Phosphorylation | LRLAEPQSQGNSQVL HHHCCCCCCCCCEEE | 51.26 | 23663014 | |
83 | Phosphorylation | EPQSQGNSQVLLDAP CCCCCCCCEEEEECC | 28.61 | 23663014 | |
95 | Ubiquitination | DAPIQLSKITENYDC ECCEEHHHHCCCCCC | 63.34 | - | |
97 | Phosphorylation | PIQLSKITENYDCGT CEEHHHHCCCCCCCC | 23.16 | 26552605 | |
100 | Phosphorylation | LSKITENYDCGTKLP HHHHCCCCCCCCCCC | 13.33 | 28796482 | |
104 | Phosphorylation | TENYDCGTKLPGLLK CCCCCCCCCCCCHHH | 35.42 | 28796482 | |
111 | Ubiquitination | TKLPGLLKREQSSTV CCCCCHHHHHHCCCC | 59.95 | - | |
115 | Phosphorylation | GLLKREQSSTVNAKK CHHHHHHCCCCCHHH | 24.19 | 30576142 | |
116 | Phosphorylation | LLKREQSSTVNAKKL HHHHHHCCCCCHHHH | 35.75 | 11660005 | |
117 | Phosphorylation | LKREQSSTVNAKKLE HHHHHCCCCCHHHHH | 24.03 | 26699800 | |
144 | Ubiquitination | RSEKDTLKTSNPLVL HCHHHHCCCCCCCHH | 52.58 | - | |
145 | Phosphorylation | SEKDTLKTSNPLVLE CHHHHCCCCCCCHHH | 36.53 | 25159151 | |
146 | Phosphorylation | EKDTLKTSNPLVLEE HHHHCCCCCCCHHHH | 34.56 | 25159151 | |
155 | Phosphorylation | PLVLEEASASQAGSR CCHHHHHCHHHCCCC | 31.56 | 23882029 | |
157 | Phosphorylation | VLEEASASQAGSRKE HHHHHCHHHCCCCCH | 20.33 | 23917254 | |
161 | Phosphorylation | ASASQAGSRKESRLE HCHHHCCCCCHHHHH | 43.10 | 28857561 | |
165 | Phosphorylation | QAGSRKESRLESSGK HCCCCCHHHHHCCCC | 45.24 | 23882029 | |
169 | Phosphorylation | RKESRLESSGKNKSY CCHHHHHCCCCCCCC | 49.32 | 23882029 | |
170 | Phosphorylation | KESRLESSGKNKSYD CHHHHHCCCCCCCCE | 44.40 | 23882029 | |
174 | Ubiquitination | LESSGKNKSYDVRIE HHCCCCCCCCEEEEE | 54.61 | - | |
218 | Phosphorylation | RNGLGKTTLLKMLAT CCCCCHHHHHHHHHH | 33.31 | 50558673 | |
225 | Phosphorylation | TLLKMLATRSLRVPA HHHHHHHHCCCCCCE | 19.48 | 20068231 | |
272 | Phosphorylation | LRRERELTAQIAAGR HHHHHHHHHHHHHHC | 16.26 | 36012617 | |
283 | Phosphorylation | AAGRAEGSEAAELAE HHHCCCCCHHHHHHH | 18.63 | 25159151 | |
288 (in isoform 2) | Ubiquitination | - | 4.43 | 21906983 | |
294 (in isoform 1) | Ubiquitination | - | 39.19 | 21906983 | |
294 | Ubiquitination | ELAEIYAKLEEIEAD HHHHHHHHHHHHHHC | 39.19 | 22053931 | |
294 | Ubiquitination | ELAEIYAKLEEIEAD HHHHHHHHHHHHHHC | 39.19 | - | |
302 | Ubiquitination | LEEIEADKAPARASV HHHHHHCCCHHHHHH | 64.42 | - | |
317 | Phosphorylation | ILAGLGFTPKMQQQP HHHHCCCCHHHHCCC | 21.87 | 26270265 | |
319 | Ubiquitination | AGLGFTPKMQQQPTR HHCCCCHHHHCCCCC | 46.40 | - | |
319 | Acetylation | AGLGFTPKMQQQPTR HHCCCCHHHHCCCCC | 46.40 | 25953088 | |
329 | Phosphorylation | QQPTREFSGGWRMRL CCCCCCCCHHHHHHH | 31.48 | 26270265 | |
411 | Phosphorylation | GYRGDFETFIKSKQE CCCCCHHHHHHHHHH | 30.56 | 24719451 | |
427 | Phosphorylation | LLNQQREYEAQQQYR HHHHHHHHHHHHHHH | 20.82 | 28796482 | |
433 | Phosphorylation | EYEAQQQYRQHIQVF HHHHHHHHHHHHHHH | 14.11 | 46156943 | |
452 | Phosphorylation | RYNANRASQVQSKLK HHCCHHHHHHHHHHH | 27.87 | 28450419 | |
457 | Ubiquitination | RASQVQSKLKMLEKL HHHHHHHHHHHHHHC | 34.73 | - | |
457 | Malonylation | RASQVQSKLKMLEKL HHHHHHHHHHHHHHC | 34.73 | 26320211 | |
457 | Acetylation | RASQVQSKLKMLEKL HHHHHHHHHHHHHHC | 34.73 | 25953088 | |
463 | Ubiquitination | SKLKMLEKLPELKPV HHHHHHHHCCCCCCC | 66.44 | - | |
468 | Ubiquitination | LEKLPELKPVDKESE HHHCCCCCCCCCCCC | 41.14 | - | |
479 | Ubiquitination | KESEVVMKFPDGFEK CCCCEEEECCCCHHH | 41.98 | - | |
512 | Phosphorylation | HVIFSRLSVSADLES CEEEEEEEECCCCCC | 16.96 | 20068231 | |
514 | Phosphorylation | IFSRLSVSADLESRI EEEEEEECCCCCCCE | 16.82 | 20068231 | |
519 | Phosphorylation | SVSADLESRICVVGE EECCCCCCCEEEECC | 33.95 | 20068231 | |
531 | Ubiquitination | VGENGAGKSTMLKLL ECCCCCCHHHHHHHH | 42.07 | - | |
536 | Ubiquitination | AGKSTMLKLLLGDLA CCHHHHHHHHHHCCH | 26.68 | - | |
616 | Ubiquitination | ASLSGGQKSRVAFAQ HHCCCCCCHHEEEEE | 43.43 | - | |
657 | Methylation | GRALNNFRGGVILVS HHHHHHCCCCEEEEE | 42.98 | - | |
686 | Phosphorylation | VCEGGGVTRVEGGFD EECCCCCEEEECCHH | 32.07 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ABCF3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ABCF3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ABCF3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ACINU_HUMAN | ACIN1 | physical | 16169070 | |
IDLC_HUMAN | DNALI1 | physical | 16169070 | |
LTOR1_HUMAN | LAMTOR1 | physical | 16169070 | |
TOE1_HUMAN | TOE1 | physical | 16169070 | |
VATB2_HUMAN | ATP6V1B2 | physical | 22939629 | |
HNRPF_HUMAN | HNRNPF | physical | 22863883 | |
CCD33_HUMAN | CCDC33 | physical | 25416956 | |
ABCF2_HUMAN | ABCF2 | physical | 26344197 | |
NLRP9_HUMAN | NLRP9 | physical | 26344197 | |
TRI27_HUMAN | TRIM27 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND MASSSPECTROMETRY. |